Validation Data Gallery
Tested Applications
Recommended dilution
| Application | Dilution |
|---|---|
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Product Information
21569-1-PBS targets NDST3 in WB, Indirect ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag16091 Product name: Recombinant human NDST3 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 180-261 aa of BC109309 Sequence: FPFSIYGNLAVKDCCINPHSPLIRVTKSSKLEKGSLPGTDWTVFQINHSAYQPVIFAKVKTPENLSPSISKGAFYATIIHDL 相同性解析による交差性が予測される生物種 |
| Full Name | N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 |
| Calculated molecular weight | 873 aa, 101 kDa |
| Observed molecular weight | 44 kDa, 64 kDa, 101 kDa |
| GenBank accession number | BC109309 |
| Gene Symbol | NDST3 |
| Gene ID (NCBI) | 9348 |
| RRID | AB_3742044 |
| Conjugate | Unconjugated |
| Form | |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | O95803 |
| Storage Buffer | PBS only{{ptg:BufferTemp}}7.3 |
| Storage Conditions | Store at -80°C. |
Background Information
NDST3 (Glucosaminyl N-deacetylase/N-sulfotransferase 3) is known to catalyze deacetylation and N-sulfation on disaccharide substrates. Aberrant NDST3 expression or tubulin acetylation has been observed in an increasing number of NDs, including amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD), schizophrenia and bipolar disorder, Alzheimer's disease (AD), and Parkinson's disease (PD) (PMID: 41268696, 34435379).